Company Filing History:
1 out of 2 
1 out of 2 Years Active: 2025
Title: Yang Sun: Innovator in CRISPR Technology
Introduction
Yang Sun is a prominent inventor based in Zhejiang, China. He is known for his significant contributions to the field of genetic engineering, particularly through his work on the CRISPR-Cas13 system. His innovative approach has the potential to revolutionize various applications in biotechnology and medicine.
Latest Patents
Yang Sun holds a patent for the "CRISPR-Cas13 system and use thereof." This invention relates to a CRISPR-Cas13 system, which includes a Cas13 protein, a fusion protein, and a guide polynucleotide. The Cas13 protein exhibits at least 90% sequence identity compared to SEQ ID NO: 1. The fusion protein consists of the Cas13 protein fused to a protein domain and/or a polypeptide tag. The guide polynucleotide features a same-direction repetition sequence and a guide sequence engineered to hybridize with the target RNA. The same-direction repetition sequence has at least 70% sequence identity to any of SEQ ID NOs: 3 and 80-87. This innovative system comprises the Cas13 protein or a coding nucleic acid, along with the guide polynucleotide or a coding nucleic acid.
Career Highlights
Throughout his career, Yang Sun has worked with notable companies such as Guangzhou Reforgene Medicine Co., Ltd. and Zhejiang Synsorbio Technology Co., Ltd. His experience in these organizations has allowed him to further develop his expertise in genetic engineering and biotechnology.
Collaborations
Yang Sun has collaborated with several professionals in his field, including Junbin Liang and Xingxiang Liang. These collaborations have contributed to the advancement of his research and innovations.
Conclusion
Yang Sun is a key figure in the development of CRISPR technology, with a focus on the CRISPR-Cas13 system. His work has the potential to impact various fields, making significant strides in genetic engineering and biotechnology.